Chemical Compound
(1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; Harpagoside; [1S-[1a,4aa,5a,7a(E),7aa]]-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[(1-oxo-3-phenyl-2-propenyl)oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; E-Harpagoside
CAS Registry Number
19210-12-9
Primary record
(1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; Harpagoside; [1S-[1a,4aa,5a,7a(E),7aa]]-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[(1-oxo-3-phenyl-2-propenyl)oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; E-Harpagoside
- 库存
- 3,644 克
- 纯度
- 99.7 %
- CAS
- 19210-12-9
化合物标识与属性
- CAS
- 19210-12-9
- PubChem CID
- 5281542
- SMILES
- C[C@@]1(C[C@H]([C@]2([C@@H]1[C@@H](OC=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)OC(=O)/C=C/C4=CC=CC=C4
- Canonical SMILES
- C[C@]1(OC(=O)/C=C/c2ccccc2)C[C@@H](O)[C@]2(O)C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]21
名称与同义词
- Harpagoside
- 19210-12-9
- E-harpagoside
- Harpagosid
- Laterioside
- Harpaside
- Harpagoside CRS
- 8KGS1DC5ZU
- AC1NQYLY
- UNII-8KGS1DC5ZU
- Harpagoside (Standard)
- RefChem:38185
- Prestwick3_000988
- BSPBio_001055
- HARPAGOSIDE [WHO-DD]
- MLS002154086
- MLS002473324
- SCHEMBL893387
- 3,4-Dichlorophenylboronic acid
- C24H30O11
- KVRQGMOSZKPBNS-FMHLWDFHSA-N
- MFCD00017415
- BPBio1_001161
- CHEBI:5625
- CHEMBL516702
- DTXSID101032528
- MEGxp0_000469
- orb1300175
- Harpagoside, analytical standard
- ACon0_000056
- ACon1_000134
- EINECS 242-881-6
- ERK5-4I12
- HY-N0396R
- DTXCID501517542
- HMS2098E17
- HMS2231N12
- HY-N0396
- ZINC8214398
- HARPAGOSIDE (REFERENCE GRADE)
- NP3892
- s9171
- WS1531
- AKOS015896715
- ACN-035401
- CCG-269650
- CID5281542
- EBC-217031
- LMPR0102070010
- MH08976
- WS 1531
- C24-H30-O11
- NCGC00179325-01
- NCGC00179325-02
- NCGC00179325-04
- NCGC00179325-05
- 4CN-1249
- AC-34268
- AS-56071
- J16.076H
- SC-19416
- SMR001233395
- AB00513986
- CS-0008931
- FT-0626864
- FT-0776572
- NS00101087
- V0696
- A13953
- C09783
- H10494
- EN300-7357122
- 210H129
- A880338
- [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate
- I07-0170
- BRD-K07996107-001-01-7
- BRD-K07996107-001-03-3
- Harpagoside, primary pharmaceutical reference standard
- Q25099323
- (1S,4aS,5R,7S,7aS)-4a,5-Dihydroxy-7-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl cinnamate
- Harpagoside, European Pharmacopoeia (EP) Reference Standard
- Harpagoside, 98%, from Harpagophytum procumbens D.C. - 10MG 10mg
- (1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1H,4aH,5H,6H,7H,7aH-cyclopenta[c]pyran-7-yl (2E)-3-phenylprop-2-enoate
- [1S-[1alpha,4aalpha,5alpha,7alpha(E),7aalpha]]-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-[(allyl-1-oxo-3-phenyl)oxy]cyclopenta[c]pyran-1-yl-beta-D-glucopyranoside
- ((1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-1,5,6,7a-tetrahydrocyclopenta(c)pyran-7-yl) (E)-3-phenylprop-2-enoate
- (1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; Harpagoside; [1S-[1a,4aa,5a,7a(E),7aa]]-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[(1-oxo-3-phenyl-2-propenyl)oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; E-Harpagoside
- (1S-(1alpha,4aalpha,5alpha,7alpha(E),7aalpha))-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-((allyl-1-oxo-3-phenyl)oxy)cyclopenta(c)pyran-1-yl-beta-D-glucopyranoside
- .BETA.-D-GLUCOPYRANOSIDE, (1S,4AS,5R,7S,7AS)-1,4A,5,6,7,7A-HEXAHYDRO-4A,5-DIHYDROXY-7-METHYL-7-(((2E)-1-OXO-3-PHENYL-2-PROPENYL)OXY)CYCLOPENTA(C)PYRAN-1-YL
- [(1S)-1,4a,5,6,7,7aalpha-Hexahydro-4aalpha,5alpha-dihydroxy-7-methyl-7alpha-[[(E)-1-oxo-3-phenyl-2-propenyl]oxy]cyclopenta[c]pyran-1alpha-yl]beta-D-glucopyranoside
- [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate
- 242-881-6
- 70206-27-8
- b-D-Glucopyranoside,(1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl
- beta-D-Glucopyranoside, 1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-((1-oxo-3-phenyl-2-propenyl)oxy)cyclopenta(c)pyran-1-yl, (1S-(1alpha,4aalpha,5alpha,7alpha(E),7aalpha))-